Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells

被引:66
作者
Salih, HR
Kosowski, SG
Haluska, VF
Starling, GC
Loo, DT
Lee, F
Aruffo, AA
Trail, PA
Kiener, PA
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Immunol Inflammat & Pulm, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Oncol Drug Discovery, Princeton, NJ 08543 USA
关键词
D O I
10.4049/jimmunol.165.5.2903
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Members of the TNF superfamily, including Fas, Fas ligand, and CD40, have been shown to be expressed on tumor cells. In the studies described in this work, we report that another family member, the ligand far 4-1BB (CD137), is expressed on various human carcinoma cell lines, on cells of solid tumors derived from these cell lines, and cells obtained from human tumors. Expression of 4-1BB ligand (4-1BBL) mRNA was detected by both RT-PCR and Northern blot analysis, and expression of 4-1BBL protein was detected by Western blot analysis of whole cell lysates and by FAGS analysis of tumor cells and cell lines. Incubation of tumor cells with a 4-1BB-Ig fusion protein led to the production of IL-8 by the cells, demonstrating that the 4-1BBL is functionally active and signals back into the tumor cells. Furthermore, 4-1BBL expressed on the carcinoma cells functioned as a costimulatory molecule for the production of cytokines (most notably IFN-gamma) in cocultures of T cells and tumor cells. These findings suggest that 4-1BBL expressed on carcinoma cells may significantly influence the outcome of a T cell-tumor cell interaction.
引用
收藏
页码:2903 / 2910
页数:8
相关论文
共 43 条
  • [31] RANKIN BM, 1993, J IMMUNOL, V150, P605
  • [32] CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
    Saoulli, K
    Lee, SY
    Cannons, JL
    Yeh, WC
    Santana, A
    Goldstein, MD
    Bangia, N
    DeBenedette, MA
    Mak, TW
    Choi, Y
    Watts, TH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) : 1849 - 1862
  • [33] SCHUERERMALY CC, 1994, IMMUNOLOGY, V81, P85
  • [34] Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
    Shiraki, K
    Tsuji, N
    Shioda, T
    Isselbacher, KJ
    Takahashi, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6420 - 6425
  • [35] 4-1BB costimulatory signals preferentially induce CD8(+) T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
    Shuford, WW
    Klussman, K
    Tritchler, DD
    Loo, DT
    Chalupny, J
    Siadak, AW
    Brown, TJ
    Emswiler, J
    Raecho, H
    Larsen, CP
    Pearson, TC
    Ledbetter, JA
    Aruffo, A
    Mittler, RS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 47 - 55
  • [36] A RECEPTOR FOR TUMOR-NECROSIS-FACTOR DEFINES AN UNUSUAL FAMILY OF CELLULAR AND VIRAL-PROTEINS
    SMITH, CA
    DAVIS, T
    ANDERSON, D
    SOLAM, L
    BECKMANN, MP
    JERZY, R
    DOWER, SK
    COSMAN, D
    GOODWIN, RG
    [J]. SCIENCE, 1990, 248 (4958) : 1019 - 1023
  • [37] THE TNF RECEPTOR SUPERFAMILY OF CELLULAR AND VIRAL-PROTEINS - ACTIVATION, COSTIMULATION, AND DEATH
    SMITH, CA
    FARRAH, T
    GOODWIN, RG
    [J]. CELL, 1994, 76 (06) : 959 - 962
  • [38] A B-LYMPHOCYTE ACTIVATION MOLECULE RELATED TO THE NERVE GROWTH-FACTOR RECEPTOR AND INDUCED BY CYTOKINES IN CARCINOMAS
    STAMENKOVIC, I
    CLARK, EA
    SEED, B
    [J]. EMBO JOURNAL, 1989, 8 (05) : 1403 - 1410
  • [39] MOLECULAR-CLONING AND EXPRESSION OF THE FAS LIGAND, A NOVEL MEMBER OF THE TUMOR-NECROSIS-FACTOR FAMILY
    SUDA, T
    TAKAHASHI, T
    GOLSTEIN, P
    NAGATA, S
    [J]. CELL, 1993, 75 (06) : 1169 - 1178
  • [40] Takahashi C, 1999, J IMMUNOL, V162, P5037